Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 245 entries
Sorted by: Best Match Show Resources per page
Cost-effectiueness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of …

Science interventions

[No authors listed]
GSID: A7F2nX57AA0J
AS Midgette, JB Wong, JR Beshansky… - Medical Decision …, 1994 - journals.sagepub.com

Objective: To determine the effects of infarct location and of the likelihood of infarction on the cost-effectiveness of intravenous streptokinase (IVSK) for suspected acute myocardial …

Cite
Midgette, A. S., Wong, J. B., Beshansky, J. R., Porath, A., Fleming, C., & Pauker, S. G. (1994). Cost-effectiueness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Medical Decision Making, 14(2), 108-117.
Midgette, Andre S., et al. "Cost-effectiueness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction." Medical Decision Making 14.2 (1994): 108-117.
Copy Download .nbib Format: MLA
The Epidemiology of Traumatic Hemothorax in a Level I Trauma Center: Case for Early Video-assisted Thoracoscopic Surgery.

European journal of trauma and emergency surgery : official publication of the European Trauma Society

MacLeod JB, Ustin JS, Kim JT, Lewis F, Rozycki GS, Feliciano DV.
PMID: 26815867
Eur J Trauma Emerg Surg. 2010 Jun;36(3):240-6. doi: 10.1007/s00068-009-9119-8. Epub 2009 Dec 22.

OBJECTIVE: Hemothorax is a common sequela of chest trauma. Complications after chest trauma include retained hemothorax and empyema requiring multiple interventions. We studied the epidemiology of hemothorax and its complications at a level I trauma center.METHODS: The trauma registry...

Cite
MacLeod JB, Ustin JS, Kim JT, et al. The Epidemiology of Traumatic Hemothorax in a Level I Trauma Center: Case for Early Video-assisted Thoracoscopic Surgery. Eur J Trauma Emerg Surg. 2009;36(3):240-6doi: 10.1007/s00068-009-9119-8.
MacLeod, J. B., Ustin, J. S., Kim, J. T., Lewis, F., Rozycki, G. S., & Feliciano, D. V. (2010). The Epidemiology of Traumatic Hemothorax in a Level I Trauma Center: Case for Early Video-assisted Thoracoscopic Surgery. European journal of trauma and emergency surgery : official publication of the European Trauma Society, 36(3), 240-6. https://doi.org/10.1007/s00068-009-9119-8
MacLeod, Jana B, et al. "The Epidemiology of Traumatic Hemothorax in a Level I Trauma Center: Case for Early Video-assisted Thoracoscopic Surgery." European journal of trauma and emergency surgery : official publication of the European Trauma Society vol. 36,3 (2010): 240-6. doi: https://doi.org/10.1007/s00068-009-9119-8
MacLeod JB, Ustin JS, Kim JT, Lewis F, Rozycki GS, Feliciano DV. The Epidemiology of Traumatic Hemothorax in a Level I Trauma Center: Case for Early Video-assisted Thoracoscopic Surgery. Eur J Trauma Emerg Surg. 2010 Jun;36(3):240-6. doi: 10.1007/s00068-009-9119-8. Epub 2009 Dec 22. PMID: 26815867.
Copy Download .nbib Format: NLM
Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase.

Journal of cardiovascular and thoracic research

Saidi H, Vakilian M, Noori GH, Ghafouri HB, Abazarian N.
PMID: 24404343
J Cardiovasc Thorac Res. 2013;5(4):139-41. doi: 10.5681/jcvtr.2013.030. Epub 2013 Dec 05.

INTRODUCTION: The role of adhesion molecules in the development and progression of coronary atherosclerosis is inevitable. It is not clear yet whether these molecules increase or decrease in level after thrombolytic therapy. This study was designed to compare concentrations...

Cite
Saidi H, Vakilian M, Noori GH, et al. Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. J Cardiovasc Thorac Res. 2013;5(4):139-41doi: 10.5681/jcvtr.2013.030.
Saidi, H., Vakilian, M., Noori, G. H., Ghafouri, H. B., & Abazarian, N. (2013). Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. Journal of cardiovascular and thoracic research, 5(4), 139-41. https://doi.org/10.5681/jcvtr.2013.030
Saidi, Hossein, et al. "Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase." Journal of cardiovascular and thoracic research vol. 5,4 (2013): 139-41. doi: https://doi.org/10.5681/jcvtr.2013.030
Saidi H, Vakilian M, Noori GH, Ghafouri HB, Abazarian N. Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. J Cardiovasc Thorac Res. 2013;5(4):139-41. doi: 10.5681/jcvtr.2013.030. Epub 2013 Dec 05. PMID: 24404343; PMCID: PMC3883535.
Copy Download .nbib Format: NLM
Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts.

ISRN pharmacology

Shivasharanappa K, Londonkar R.
PMID: 25006495
ISRN Pharmacol. 2014 Mar 31;2014:975303. doi: 10.1155/2014/975303. eCollection 2014.

The present study was carried out to investigate the thrombolytic and antimitotic potentiality of various extracts of fruits of Ficus glomerata, a traditional medicinal plant, using an in vitro assay method. Three crude extracts such as petroleum ether (FGPE),...

Cite
Shivasharanappa K, Londonkar R. Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts. ISRN Pharmacol. 2014;2014:975303doi: 10.1155/2014/975303.
Shivasharanappa, K., & Londonkar, R. (2014). Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts. ISRN pharmacology, 2014975303. https://doi.org/10.1155/2014/975303
Shivasharanappa, Kirankumar, and Londonkar, Ramesh. "Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts." ISRN pharmacology vol. 2014 (2014): 975303. doi: https://doi.org/10.1155/2014/975303
Shivasharanappa K, Londonkar R. Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts. ISRN Pharmacol. 2014 Mar 31;2014:975303. doi: 10.1155/2014/975303. eCollection 2014. PMID: 25006495; PMCID: PMC4003911.
Copy Download .nbib Format: NLM
A microculture technique in the evaluation of lymphocyte transformation by mitogens and specific antigens in humans.

Irish journal of medical science

Woods RJ, Greally JF.
PMID: 27517258
Ir J Med Sci. 1976 Dec;145(1):369-77. doi: 10.1007/BF02938974.

A micro method forin vitro transformation of lymphocytes (Penhaleet al., 1974) by mitogens and antigens is presented. Using a range of concentrations, satisfactory responses were obtained with small numbers of lymphocytes in the presence of the mitogens, phytohaemagglutinin-P, Concanavalin-A,...

Cite
Woods RJ, Greally JF. A microculture technique in the evaluation of lymphocyte transformation by mitogens and specific antigens in humans. Ir J Med Sci. 1976;145(1):369-77doi: 10.1007/BF02938974.
Woods, R. J., & Greally, J. F. (1976). A microculture technique in the evaluation of lymphocyte transformation by mitogens and specific antigens in humans. Irish journal of medical science, 145(1), 369-77. https://doi.org/10.1007/BF02938974
Woods, R J, and Greally, J F. "A microculture technique in the evaluation of lymphocyte transformation by mitogens and specific antigens in humans." Irish journal of medical science vol. 145,1 (1976): 369-77. doi: https://doi.org/10.1007/BF02938974
Woods RJ, Greally JF. A microculture technique in the evaluation of lymphocyte transformation by mitogens and specific antigens in humans. Ir J Med Sci. 1976 Dec;145(1):369-77. doi: 10.1007/BF02938974. PMID: 27517258.
Copy Download .nbib Format: NLM
In vitro thrombolytic potential of root extracts of four medicinal plants available in Bangladesh.

Ancient science of life

Hussain F, Islam A, Bulbul L, Moghal MR, Hossain MS.
PMID: 25538351
Anc Sci Life. 2014 Jan;33(3):162-4. doi: 10.4103/0257-7941.144620.

CONTEXT: Thrombus formation inside the blood vessels obstructs blood flow through the circulatory system leading hypertension, stroke to the heart, anoxia, and so on. Thrombolytic drugs are widely used for the management of cerebral venous sinus thrombosis patients, but...

Cite
Hussain F, Islam A, Bulbul L, et al. In vitro thrombolytic potential of root extracts of four medicinal plants available in Bangladesh. Anc Sci Life. 2014;33(3):162-4doi: 10.4103/0257-7941.144620.
Hussain, F., Islam, A., Bulbul, L., Moghal, M. R., & Hossain, M. S. (2014). In vitro thrombolytic potential of root extracts of four medicinal plants available in Bangladesh. Ancient science of life, 33(3), 162-4. https://doi.org/10.4103/0257-7941.144620
Hussain, Fahad, et al. "In vitro thrombolytic potential of root extracts of four medicinal plants available in Bangladesh." Ancient science of life vol. 33,3 (2014): 162-4. doi: https://doi.org/10.4103/0257-7941.144620
Hussain F, Islam A, Bulbul L, Moghal MR, Hossain MS. In vitro thrombolytic potential of root extracts of four medicinal plants available in Bangladesh. Anc Sci Life. 2014 Jan;33(3):162-4. doi: 10.4103/0257-7941.144620. PMID: 25538351; PMCID: PMC4264304.
Copy Download .nbib Format: NLM
Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense.

Journal of thrombosis and thrombolysis

Brieger D, Topol E.
PMID: 10639635
J Thromb Thrombolysis. 1997;4(3):325-327. doi: 10.1023/a:1008832913207.

Two large multicenter clinical trials comparing heparin with hirudin in the management of patients with acute coronary syndromes have recently been completed. Direct thrombin inhibition was reported to result in only a modest reduction in the incidence of primary...

Cite
Brieger D, Topol E. Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense. J Thromb Thrombolysis. 1997;4(3):325-327doi: 10.1023/a:1008832913207.
Brieger, D., & Topol, E. (1997). Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense. Journal of thrombosis and thrombolysis, 4(3), 325-327. https://doi.org/10.1023/a:1008832913207
Brieger, and Topol. "Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense." Journal of thrombosis and thrombolysis vol. 4,3 (1997): 325-327. doi: https://doi.org/10.1023/a:1008832913207
Brieger D, Topol E. Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense. J Thromb Thrombolysis. 1997;4(3):325-327. doi: 10.1023/a:1008832913207. PMID: 10639635.
Copy Download .nbib Format: NLM
Thrombolytic therapy with streptokinase.

The Medical journal of Australia

Biggs JC, Chesterman CN.
PMID: 5541605
Med J Aust. 1971 Jan 16;1(3):171.

No abstract available.

Cite
Biggs JC, Chesterman CN. Thrombolytic therapy with streptokinase. Med J Aust. 1971;1(3):171
Biggs, J. C., & Chesterman, C. N. (1971). Thrombolytic therapy with streptokinase. The Medical journal of Australia, 1(3), 171.
Biggs, J C, and Chesterman, C N. "Thrombolytic therapy with streptokinase." The Medical journal of Australia vol. 1,3 (1971): 171.
Biggs JC, Chesterman CN. Thrombolytic therapy with streptokinase. Med J Aust. 1971 Jan 16;1(3):171. PMID: 5541605.
Copy Download .nbib Format: NLM
New Accelerated rt-PA Strategy Has Sufficient Advantage over Older Streptokinase Strategies that It should Be the Trhombolytic Strategy of Choice in Anterior and Large Infarctions.

American journal of therapeutics

Meyer BJ, Chesebro JH.
PMID: 11847539
Am J Ther. 1995 Feb;2(2):123-127. doi: 10.1097/00045391-199502000-00008.

The major goal of myocardial reperfusion therapy is to restore normal coronary blood flow as quickly as possible and to maintain coronary patency in the highest number of patients with acute myocardial infarction. Recent studies support the hypothesis that...

Cite
Meyer BJ, Chesebro JH. New Accelerated rt-PA Strategy Has Sufficient Advantage over Older Streptokinase Strategies that It should Be the Trhombolytic Strategy of Choice in Anterior and Large Infarctions. Am J Ther. 1995;2(2):123-127doi: 10.1097/00045391-199502000-00008.
Meyer, B. J., & Chesebro, J. H. (1995). New Accelerated rt-PA Strategy Has Sufficient Advantage over Older Streptokinase Strategies that It should Be the Trhombolytic Strategy of Choice in Anterior and Large Infarctions. American journal of therapeutics, 2(2), 123-127. https://doi.org/10.1097/00045391-199502000-00008
Meyer, Beat J., and Chesebro, James H.. "New Accelerated rt-PA Strategy Has Sufficient Advantage over Older Streptokinase Strategies that It should Be the Trhombolytic Strategy of Choice in Anterior and Large Infarctions." American journal of therapeutics vol. 2,2 (1995): 123-127. doi: https://doi.org/10.1097/00045391-199502000-00008
Meyer BJ, Chesebro JH. New Accelerated rt-PA Strategy Has Sufficient Advantage over Older Streptokinase Strategies that It should Be the Trhombolytic Strategy of Choice in Anterior and Large Infarctions. Am J Ther. 1995 Feb;2(2):123-127. doi: 10.1097/00045391-199502000-00008. PMID: 11847539.
Copy Download .nbib Format: NLM
Streptokinase Is Still the Agent of Choice for Most Patients with Myocardial Infarction.

American journal of therapeutics

Sleight P.
PMID: 11847540
Am J Ther. 1995 Feb;2(2):128-135. doi: 10.1097/00045391-199502000-00009.

I believe streptokinase is still the trombolytic of choice for the majority of patients with acute myocardial infarction for the following reasons: 1. The superiority of alteplase over streptokinase rests on insecure grounds, statistically (when net clinical benefit is...

Cite
Sleight P. Streptokinase Is Still the Agent of Choice for Most Patients with Myocardial Infarction. Am J Ther. 1995;2(2):128-135doi: 10.1097/00045391-199502000-00009.
Sleight, P. (1995). Streptokinase Is Still the Agent of Choice for Most Patients with Myocardial Infarction. American journal of therapeutics, 2(2), 128-135. https://doi.org/10.1097/00045391-199502000-00009
Sleight, Peter. "Streptokinase Is Still the Agent of Choice for Most Patients with Myocardial Infarction." American journal of therapeutics vol. 2,2 (1995): 128-135. doi: https://doi.org/10.1097/00045391-199502000-00009
Sleight P. Streptokinase Is Still the Agent of Choice for Most Patients with Myocardial Infarction. Am J Ther. 1995 Feb;2(2):128-135. doi: 10.1097/00045391-199502000-00009. PMID: 11847540.
Copy Download .nbib Format: NLM
Tissue-type plasminogen activator: characteristics, applications and production technology.

Biotechnology advances

Rouf SA, Moo-Young M, Chisti Y.
PMID: 14537155
Biotechnol Adv. 1996;14(3):239-66. doi: 10.1016/0734-9750(96)00019-5.

Plasminogen activators have immense clinical significance as thrombolytic agents for management of stroke and myocardial infarction. Tissue-type plasminogen activator (tPA) is generally preferred as being effective and safer than either urokinase or streptokinase type activators. Large-scale production of tPA...

Cite
Rouf SA, Moo-Young M, Chisti Y. Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnol Adv. 1996;14(3):239-66doi: 10.1016/0734-9750(96)00019-5.
Rouf, S. A., Moo-Young, M., & Chisti, Y. (1996). Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnology advances, 14(3), 239-66. https://doi.org/10.1016/0734-9750(96)00019-5
Rouf, S A, et al. "Tissue-type plasminogen activator: characteristics, applications and production technology." Biotechnology advances vol. 14,3 (1996): 239-66. doi: https://doi.org/10.1016/0734-9750(96)00019-5
Rouf SA, Moo-Young M, Chisti Y. Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnol Adv. 1996;14(3):239-66. doi: 10.1016/0734-9750(96)00019-5. PMID: 14537155.
Copy Download .nbib Format: NLM
The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies.

Iranian journal of allergy, asthma, and immunology

Afshari A, Holme RE.
PMID: 17301402
Iran J Allergy Asthma Immunol. 2004 Sep;3(3):121-5. doi: 03.03/ijaai.121125.

The measurement of anti-streptokinase antibodies can distinguish the patients who may benefit from streptokinase and those who should be treated with some other thrombolytic regimen. Neutralising titration test is a commonly used classical assay for measuring anti-streptokinase antibodies and...

Cite
Afshari A, Holme RE. The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies. Iran J Allergy Asthma Immunol. 2004;3(3):121-5doi: 03.03/ijaai.121125.
Afshari, A., & Holme, R. E. (2004). The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies. Iranian journal of allergy, asthma, and immunology, 3(3), 121-5. https://doi.org/03.03/ijaai.121125
Afshari, Afshin, and Holme, R Elizbeth. "The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies." Iranian journal of allergy, asthma, and immunology vol. 3,3 (2004): 121-5. doi: https://doi.org/03.03/ijaai.121125
Afshari A, Holme RE. The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies. Iran J Allergy Asthma Immunol. 2004 Sep;3(3):121-5. doi: 03.03/ijaai.121125. PMID: 17301402.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 245 entries